Skip to content

Clinical trials

Completed Phase 2 Endometrial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Status: Completed Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20018
20026
20033
20046
20056
20067
200711
20086
20093
20103
20115
20123
20132
20143
20152
20165
20179
20185
20196
20203
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Gynecologic Oncology Group8
M.D. Anderson Cancer Center7
Memorial Sloan Kettering Cancer Center6
European Organisation for Research and Treatment of Cancer - EORTC4
Masonic Cancer Center, University of Minnesota4
Merck Sharp & Dohme LLC4
ARCAGY/ GINECO GROUP3
NCIC Clinical Trials Group3
NYU Langone Health3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms124
Ovarian Neoplasms20
Uterine Cervical Neoplasms20
Neoplasms12
Uterine Neoplasms10
Sarcoma8
Sarcoma, Endometrial Stromal8
Breast Neoplasms6
Carcinoma, Ovarian Epithelial6
Fallopian Tube Neoplasms6

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.